Literature DB >> 2448876

The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors.

S M Goyert1, E Ferrero, W J Rettig, A K Yenamandra, F Obata, M M Le Beau.   

Abstract

CD14 is a myelomonocytic differentiation antigen expressed by monocytes, macrophages, and activated granulocytes and is detectable with the monoclonal antibodies MO2, MY4, and LeuM3. Analyses of complementary DNA and genomic clones of CD14 show that it has a novel structure and that it maps to chromosome 5 within a region containing other genes encoding growth factors and receptors; it may therefore represent a new receptor important for myeloid differentiation. In addition, the CD14 gene is included in the "critical" region that is frequently deleted in certain myeloid leukemias.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448876     DOI: 10.1126/science.2448876

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  67 in total

1.  The lipopolysaccharide co-receptor CD14 is present and functional in seminal plasma and expressed on spermatozoa.

Authors:  C L Harris; M A Vigar; J E Rey Nores; V Horejsi; M O Labeta; B P Morgan
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

Review 2.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

3.  Interferon gamma abrogates the differentiation block in v-myc-expressing U-937 monoblasts.

Authors:  F Oberg; L G Larsson; R Anton; K Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

Review 4.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

5.  Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14.

Authors:  M Arditi; J Zhou; R Dorio; G W Rong; S M Goyert; K S Kim
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

Review 6.  The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin.

Authors:  R R Schumann; E T Rietschel; H Loppnow
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

7.  Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36.

Authors:  Nadra J Nilsen; Susanne Deininger; Unni Nonstad; Frode Skjeldal; Harald Husebye; Dmitrii Rodionov; Sonja von Aulock; Thomas Hartung; Egil Lien; Oddmund Bakke; Terje Espevik
Journal:  J Leukoc Biol       Date:  2008-05-05       Impact factor: 4.962

8.  Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression.

Authors:  Bing Du; Weijia Luo; Ruimei Li; Binghe Tan; Honghui Han; Xiaoling Lu; Dali Li; Min Qian; Dekai Zhang; Yongxiang Zhao; Mingyao Liu
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

9.  Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells.

Authors:  Xiaolei Tang; David E Yocum; David DeJonghe; Kathy Nordensson
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

10.  Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide.

Authors:  E Ferrero; D Jiao; B Z Tsuberi; L Tesio; G W Rong; A Haziot; S M Goyert
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.